Volume 21, Issue 11 p. 1941-1946
Research Article

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

Claire Ardouin MA

Claire Ardouin MA

Département de Neurologie, CHU Grenoble, INSERM U318, Université Joseph Fourier, Grenoble, France

Search for more papers by this author
Valerie Voon MD

Valerie Voon MD

Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada

Search for more papers by this author
Yulia Worbe MD

Yulia Worbe MD

Centre d'Investigation Clinique 9503, INSERM U679, CHU Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France

Search for more papers by this author
Nehman Abouazar MD

Nehman Abouazar MD

Département de Neurologie, CHU Grenoble, INSERM U318, Université Joseph Fourier, Grenoble, France

Search for more papers by this author
Virginie Czernecki MA

Virginie Czernecki MA

Centre d'Investigation Clinique 9503, INSERM U679, CHU Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France

Search for more papers by this author
Hassan Hosseini MD

Hassan Hosseini MD

Service de Neurologie, Hôpital Henri Mondor, Créteil, France

Search for more papers by this author
Antoine Pelissolo MD

Antoine Pelissolo MD

Psychiatrie UMR7593, Pitié- Salpêtrière, Paris, France

Search for more papers by this author
Elena Moro MD

Elena Moro MD

Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada

Search for more papers by this author
Eugénie Lhommée MA

Eugénie Lhommée MA

Département de Neurologie, CHU Grenoble, INSERM U318, Université Joseph Fourier, Grenoble, France

Search for more papers by this author
Anthony E. Lang MD

Anthony E. Lang MD

Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada

Search for more papers by this author
Yves Agid MD

Yves Agid MD

Centre d'Investigation Clinique 9503, INSERM U679, CHU Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France

Search for more papers by this author
Alim-Louis Benabid MD

Alim-Louis Benabid MD

Service de Neurochirurgie, CHU Grenoble, INSERM U318, Université Joseph Fourier, Grenoble, France

Search for more papers by this author
Pierre Pollak MD

Pierre Pollak MD

Département de Neurologie, CHU Grenoble, INSERM U318, Université Joseph Fourier, Grenoble, France

Search for more papers by this author
Luc Mallet MD

Luc Mallet MD

Centre d'Investigation Clinique 9503, INSERM U679, CHU Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France

Psychiatrie UMR7593, Pitié- Salpêtrière, Paris, France

Search for more papers by this author
Paul Krack MD

Corresponding Author

Paul Krack MD

Département de Neurologie, CHU Grenoble, INSERM U318, Université Joseph Fourier, Grenoble, France

Département de Neurologie, Centre Hospitalier Universitaire de Grenoble, BP 217, 38043 Grenoble Cedex 9, FranceSearch for more papers by this author
First published: 13 September 2006
Citations: 204

Abstract

Pathological gambling (PG) related to dopaminergic treatment in Parkinson's disease (PD) is part of a spectrum of behavioral disorders called the dopamine dysregulation syndrome (DDS). We describe a series of PD patients with preoperative active PG due to dopaminergic treatment from a total of 598 patients who have undergone surgery for subthalamic nucleus stimulation for disabling motor fluctuations. The patients had systematic open assessment of behavioral symptoms and standardized assessments of motor symptoms, mood, and apathy. Seven patients (6 men, 1 woman; age, 54 ± 9 years; levodopa equivalent dose, 1,390 ± 350 mg/day) had preoperative PG over a mean of 7 years, intolerant to reduction in medication. Six had nonmotor fluctuations and four had other behavioral symptoms consistent with a diagnosis of the DDS. After surgery, motor symptoms improved, allowing for 74% reduction of dopaminergic treatment, below the dosage of gambling onset. In all patients, PG resolved postoperatively after 18 months on average (range, 0–48), although transient worsening occurred in two. Improvement paralleled the time course and degree of reduction in dopaminergic treatment. Nonmotor fluctuations, off period dysphoria, and other symptoms of the DDS improved. Two patients developed persistent apathy. In conclusion, PG and other symptoms of the DDS-associated dopaminergic treatment improved in our patients following surgery. Dopaminergic dysregulation commonly attributed to pulsatile overstimulation of the limbic dopaminergic system may be subject to desensitization on chronic subthalamic stimulation, which has a relative motor selectivity and allows for decrease in dopaminergic treatment. © 2006 Movement Disorder Society